USING EXTRACT OF CISTANCHE TUBULOSA IN PREPARING MEDICINAL PRODUCTS OR FOOD PRODUCTS FOR EYE CELLS PROTECTION Russian patent published in 2019 - IPC A61K36/896 A61K31/70 A61P27/02 

Abstract RU 2688939 C2

FIELD: medicine; pharmaceuticals; food industry.

SUBSTANCE: invention refers to pharmaceutical and food industry, namely to application of Cistanche tubulosa extract for production of product for prevention, retardation or treatment of eye diseases caused by oxidative stress induced by tert-butyl hydroperoxide (t-BHP), ischemia or blue light. Use of the extract of Cistanche tubulosa for preparing a drug for preventing, slowing or treating eye diseases caused by oxidative stress induced by tert-butyl hydroperoxide (t-BHP), ischemia or blue light, wherein the extract of Cistanche tubulosa contains a component selected from a group consisting of echinacid, actezide, isoachtoiside, tubulozide A or a combination thereof. Use of a component of a Cistanche tubulosa extract selected from a group comprising echinACoside, actoteside, isoachtoside, tubuloside A or a combination thereof, for preparing a medicinal agent for preventing, slowing or treating eye diseases caused by oxidative stress induced by tert-butyl hydroperoxide (t-BHP), ischemia or blue light. Application of Cistanche tubulosa extract for food product preparation for protection of eye cells from damage caused by oxidative stress induced by tert-butyl hydroperoxide (t-BHP), ischemia or blue light, wherein Cistanche tubulosa extract contains a component selected from the group consisting of echinacoside, actezide, isoachtoiside, tubuloside A or a combination thereof. Use of a component of a Cistanche tubulosa extract selected from a group comprising echinACoside, actoteside, isoachtoside, tubuloside A or a combination thereof, for preparing a food product for protecting the eye cells from damage caused by oxidative stress induced by tert-butyl hydroperoxide (t-BHP), ischemia or blue light. Use of the extract of Cistanche tubulosa for preparing a medicinal agent for protecting the eye cells from damage caused by oxidative stress induced by tert-butyl hydroperoxide (t-BHP), ischemia or blue light, wherein the extract of Cistanche tubulosa contains a component selected from a group consisting of echinacoside, actoteside, isoachtoiside, tubuloside A or a combination thereof. Use of a component of a Cistanche tubulosa extract selected from a group comprising echinACoside, actoteside, isoachtoside, tubuloside A or a combination thereof, for preparing a medicinal agent for protecting the eye cells from damage caused by oxidative stress induced by tert-butyl hydroperoxide (t-BHP), ischemia or blue light.

EFFECT: agents described above are effective for protecting eye cells from damage caused by oxidative stress induced by tert-butyl hydroperoxide (t-BHP), ischemia or blue light, or for preventing, slowing or treating eye diseases caused by oxidative stress induced by tert-butyl hydroperoxide (t-BHP), ischemia or blue light.

19 cl, 25 dwg, 3 tbl, 2 ex

Similar patents RU2688939C2

Title Year Author Number
DRUG FOR GLUCOSE LEVEL REGULATION IN BLOOD 2014
  • Kong Zwe-Ling
  • Ko Fan-Chi
  • Yeh Ai-Ling
RU2637635C2
THERAPEUTIC AND NEUROPROTECTIVE PEPTIDES 2018
  • Karageozian, Khampar, L.
  • Park, Dzhon, I.
  • Karageozian, Viken, Kh.
RU2788097C2
TREATMENT OF EYE DISEASES SUCH AS MACULAR DEGENERATION, GLAUCOMA AND DIABETIC RETINOPATHY WITH MEDICATIONS THAT ELIMINATE AGING CELLS 2018
  • Hopkins, Jill
  • Tsuruda, Pam
  • Chapman, Claude
  • Sweigard, Harry
  • Poon, Yan
  • Marquess, Daniel
  • David, Nathaniel
  • Dananberg, Jamie
  • Laberge, Remi-Martin
RU2815482C2
PROPHYLACTIC AND THERAPEUTIC DRUG FOR AGE-RELATED MACULAR DEGENERATION 2008
  • Khirai Sin-Itiro
  • Esida Atsusi
RU2460526C2
INHIBITORS OF HYSTONE DEACETYLASE FOR TREATMENT OF DEGENERATIVE EYE DISEASES 2003
  • Khellberg Peggi Eh.
RU2324483C2
COMPOSITION FOR PREVENTING OR TREATING EYE DISEASES, CONTAINING S-ALLYL-L-CYSTEIN AS ACTIVE INGREDIENT, AND PHARMACEUTICAL PREPARATION CONTAINING IT 2013
  • Kim Soon Bae
  • Kim Gvang Soon
  • Kim Van Bae
  • Kvak Vie Dzong
  • Dzeon Sun Duk
  • Joon Khiung Joung
  • Dzang Jang Pio
RU2605618C2
LOCAL EYE PEPTIDE COMPOSITION 2010
  • Simo Kanonkhe Rafaehl'
  • Hernandez Pascual Cristina
  • Fernandes Karneado Khimena
  • Gomes Kaminal'S Mark
  • Jordana I Lluch Ribera
  • Farrera Sunfreu Josep
  • Ponsati Obiols Berta
RU2561585C2
PREVENTIVE AND THERAPEUTIC AGENT FOR POSTERIOR EYE DISEASES 2008
  • Okamoto Kazuesi
  • Sibagaki Keiiti
RU2470635C2
NANOSTRUCTURED COMPOSITIONS FOR DELIVERY OF SILIBININ AND OTHER ACTIVE INGREDIENTS FOR TREATING EYE DISEASES 2015
  • Consoli, Grazia Maria Letizia
  • Cavallaro, Gennara
  • Bondi', Maria Luisa
  • Blanco, Anna Rita
  • Viola, Santa
  • Esposito, Emanuela
  • Cuzzocrea, Salvatore
  • Guarneri, Patrizia
  • Papasergi, Salvatore
  • Deidda, Irene
  • La Marca, Clara
  • Saladino, Patrizia
  • Granata, Giuseppe
  • Pitarresi, Giovanna
  • Licciardi, Mariano
  • Giammona, Gaetano
  • Craparo, Emanuela Fabiola
RU2726193C2
SUNITINIB-BASED COMPOSITIONS AND METHODS FOR USING THEM FOR TREATING EYE DISEASES 2015
  • Fu Tsze
  • Khejns Dzhasti
  • Kajs Dzhoshua
  • Yu Yun
  • Yan Min
  • Klilend Dzheffri
  • Stark Uolter Dzh.
  • Syuj Tsinguo
  • Yan Tszin
RU2729731C2

RU 2 688 939 C2

Authors

Lee Chih-Wen

Dates

2019-05-23Published

2015-07-03Filed